Senate bill would repeal competitive bidding demo
This article was originally published in The Gray Sheet
A Senate bill (S. 2099) to repeal CMS' competitive bidding demonstration project for clinical laboratories is introduced Sept. 26 and applauded by the American Clinical Laboratory Association. ACLA is lobbying Sens. Max Baucus (D-Mont.) and Charles Grassley (R-Iowa) to attach language in the bill to a separate package of Medicare reform provisions that Congress is expected to consider this year. Introduced by Sens. Ken Salazar (D-Col.), Pat Roberts (R-Kan.) and Maria Cantwell (D-Wash.), the bill mirrors similar legislation in the House (H.R. 3453) to stop CMS from carrying out the demonstration project to assess the cost-saving potential of replacing Medicare's lab fee schedule with prices based on the lowest bids from labs ("1The Gray Sheet" Aug. 13, 2007, p. 8)
You may also be interested in...
A bill introduced in the House Aug. 4 would cancel a Medicare clinical laboratory services competitive bidding demonstration project before it begins
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.